Results from Transwell experiments showed that the overexpression of TCF7L2 reversed the inhibitory effect of METTL3 knockdown on ccRCC cell migration and invasion (Fig. S9C and D). Here, TCF7L2 is linked to nonpapillary renal cell carcinoma.